|
1
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong SK, Yang SY, Yin SH and Yang KX:
RC-3095, a gastrin-releasing peptide receptor antagonist,
synergizes with gemcitabine to inhibit the growth of human
pancreatic cancer CFPAC-1 in vitro and in vivo. Pancreas. 43:15–21.
2014. View Article : Google Scholar
|
|
4
|
Karakhanova S, Mosl B, Harig S, von Ahn K,
Fritz J, Schmidt J, Jäger D, Werner J and Bazhin AV: Influence of
interferon-alpha combined with chemo (radio) therapy on
immunological parameters in pancreatic adenocarcinoma. Int J Mol
Sci. 15:4104–4125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qu C and Chen Z: Antitumor effect of water
decoctions of Taxus cuspidate on pancreatic cancer. Evid Based
Complement Alternat Med. 2014:2916752014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laquente B, Lacasa C, Ginestà MM,
Casanovas O, Figueras A, Galán M, Ribas IG, Germà JR, Capellà G and
Viñals F: Antiangiogenic effect of gemcitabine following metronomic
administration in a pancreas cancer model. Mol Cancer Ther.
7:638–647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Reilly EM: Adjuvant therapy for pancreas
adenocarcinoma: Where are we going? Expert Rev Anticancer Ther.
11:173–177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burris HA III, Moore MJ, Andersen J, Green
MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo
AM, Tarassoff P, et al: Improvements in survival and clinical
benefit with gemcitabine as first-line therapy for patients with
advanced pancreas cancer: A randomized trial. J Clin Oncol.
15:2403–2413. 1997.PubMed/NCBI
|
|
9
|
Moore MJ, Goldstein D, Hamm J, Figer A,
Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, et al
National Cancer Institute of Canada Clinical Trials Group:
Erlotinib plus gemcitabine compared with gemcitabine alone in
patients with advanced pancreatic cancer: A phase III trial of the
National Cancer Institute of Canada Clinical Trials Group. J Clin
Oncol. 25:1960–1966. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Isayama H, Nakai Y, Yamamoto K, Sasaki T,
Mizuno S, Yagioka H, Yashima Y, Kawakubo K, Kogure H, Arizumi T, et
al: Gemcitabine and oxaliplatin combination chemotherapy for
patients with refractory pancreatic cancer. Oncology. 80:97–101.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khalil MA, Qiao W, Carlson P, George B,
Javle M, Overman M, Varadhachary G, Wolff RA, Abbruzzese JL and
Fogelman DR: The addition of erlotinib to gemcitabine and cisplatin
does not appear to improve median survival in metastatic pancreatic
cancer. Invest New Drugs. 31:1375–1383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S, Wu X, Tan M, Gong J, Tan W, Bian
B, Chen M and Wang Y: Fighting fire with fire: Poisonous Chinese
herbal medicine for cancer therapy. J Ethnopharmacol. 140:33–45.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi YK, Cho SG, Woo SM, Yun YJ, Park S,
Shin YC and Ko SG: Herbal extract SH003 suppresses tumor growth and
metastasis of MDA-MB-231 breast cancer cells by inhibiting
STAT3-IL-6 signaling. Mediators Inflamm. 2014:4921732014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sikdar S, Mukherjee A, Ghosh S and
Khuda-Bukhsh AR: Condurango glycoside-rich components stimulate DNA
damage-induced cell cycle arrest and ROS-mediated caspase-3
dependent apoptosis through inhibition of cell-proliferation in
lung cancer, in vitro and in vivo. Environ Toxicol Pharmacol.
37:300–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu J and Chen Q: Antitumor activities of
Rauwolfia vomitoria extract and potentiation of gemcitabine effects
against pancreatic cancer. Integr Cancer Ther. 13:217–225. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim MP, Evans DB, Wang H, Abbruzzese JL,
Fleming JB and Gallick GE: Generation of orthotopic and heterotopic
human pancreatic cancer xenografts in immunodeficient mice. Nat
Protoc. 4:1670–1680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung HJ, Pak PJ, Park SH, Ju JE, Kim JS,
Lee HS and Chung N: Silver wire amplifies the signaling mechanism
for IL-1beta production more than silver submicroparticles in human
monocytic THP-1 cells. PLoS One. 9:e1122562014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park SH, Sung JH, Kim EJ and Chung N:
Berberine induces apoptosis via ROS generation in PANC-1 and
MIA-PaCa2 pancreatic cell lines. Braz J Med Biol Res. 48:111–119.
2015. View Article : Google Scholar :
|
|
19
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu J: Statistical inference for tumor
growth inhibition T/C ratio. J Biopharm Stat. 20:954–964. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lang F, Gulbins E, Lerche H, Huber SM,
Kempe DS and Foller M: Eryptosis, a window to systemic disease.
Cell Physiol Biochem. 22:373–380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Efferth T, Li PC, Konkimalla VS and Kaina
B: From traditional Chinese medicine to rational cancer therapy.
Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koppikar SJ, Choudhari AS, Suryavanshi SA,
Kumari S, Chattopadhyay S and Kaul-Ghanekar R: Aqueous cinnamon
extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis
in human cervical cancer cell line (SiHa) through loss of
mitochondrial membrane potential. BMC Cancer. 10:2102010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang JW and Wei YH: Anti-cancer effects
of Grailsine-Al-glycoside isolated from Rhizoma Sparganii. BMC
Complement Altern Med. 14:822014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie F, Zhang M, Zhang CF, Wang ZT, Yu BY
and Kou JP: Anti-inflammatory and analgesic activities of ethanolic
extract and two limonoids from Melia toosendan fruit. J
Ethnopharmacol. 117:463–466. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Makin G and Hickman JA: Apoptosis and
cancer chemotherapy. Cell Tissue Res. 301:143–152. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li L and Leung PS: Use of herbal medicines
and natural products: An alternative approach to overcoming the
apoptotic resistance of pancreatic cancer. Int J Biochem Cell Biol.
53:224–236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abel EV and Simeone DM: Biology and
clinical applications of pancreatic cancer stem cells.
Gastroenterology. 144:1241–1248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar D, Shankar S and Srivastava RK:
Rottlerin induces autophagy and apoptosis in prostate cancer stem
cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett.
343:179–189. 2014. View Article : Google Scholar
|
|
30
|
Suntharalingam K, Lin W, Johnstone TC,
Bruno PM, Zheng YR, Hemann MT and Lippard SJ: A breast cancer stem
cell-selective, mammospheres-potent osmium(VI) nitrido complex. J
Am Chem Soc. 136:14413–14416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hashimoto N, Tsunedomi R, Yoshimura K,
Watanabe Y, Hazama S and Oka M: Cancer stem-like sphere cells
induced from de-differentiated hepatocellular carcinoma-derived
cell lines possess the resistance to anti-cancer drugs. BMC Cancer.
14:7222014. View Article : Google Scholar : PubMed/NCBI
|
